A transition from the use of HFA 134a and HFA 227 as propellants in metered dose inhalers (MDIs) to lower global warming potential (LGWP) propellants is in the early stages
Learn more about these LGWP propellants:
Learn more about the transition:
View IPAC-RS’s October 11, 2023 Workshop on the Transition to Low Global Warming Potential Propellants for Metered Dose Inhalers
Recent news about LGWP propellants:
-
OzUK announces new GLP pilot plant for development of MDIs with LGWP propellants
-
Honeywell announces agreement to supply HFO 1234ze for DevPro albuterol MDI, spin off of the advanced materials business
-
Bespak and H&T Presspart launch new GMP pilot-scale MDI filling line for LGWP propellants
-
AstraZeneca says that it has completed studies to support regulatory submissions for LGWP propellant version of Breztri (Trixeo) Aerosphere MDI
-
Bespak announces that it will soon allocate capacity for new LGWP MDI filling line
-
Bespak and DevPro developing HFO-1234ze albuterol MDI
-
Kindeva to add additional LGWP propellant MDI manufacturing line
-
Bespak and H&T Presspart announce partnership on LGWP propellant transition services
-
Mundipharma and Vectura partner on LGWP reformulation of Flutiform MDI
-
Chiesi initiates Phase 3 trial of HFA 152a version of its Trimbow MDI